Expresión de CD44 HCAM en el carcinoma subseroso de la vesícula biliar / CD44 HCAM expression in subserous gallbladder carcinoma
Rev. méd. Chile
;
129(7): 727-734, jul. 2001. ilus, tab, graf
Artigo
em Espanhol
| LILACS
| ID: lil-300037
ABSTRACT
Background:
HCAM or CD44 is a multifunctional cell adhesion molecule, related to cell-cell, cell-extracellular matrix interactions and involved in tumor invasion.Aim:
To study the importance of CD44 expression in subserous gallbladder carcinoma. Material andmethods:
One hundred five samples (93 female) of subserous gallbladder carcinoma and 33 non tumoral gallbladder were studied. CD44 was stained using the streptavidine-biotin technique, using human anti CD44 antibodies. Eighty subjects with carcinoma were followed for a period up to 105 months.Results:
Mean age of patients was 62,6 years old, all tumors were adenocarcinoma, all were silent and 13 percent were well differentiated. CD44 was expressed in all controls and in 91 percent, the expression was normal. In 57 percent of cancer samples, CD44 expression was abnormal, in 50 percent it was less expressed and in 24 percent, it was not expressed. No differences in CD44 expression was observed between mucosa from control samples and mucosa adjacent to the tumor or superficial or deep tumoral areas. Global five years survival was 40 percent. No significant differences in survival were observed in those tumors with a lower of absent CD44 expression. Six patients with a higher expression died before 18 months of follow up.Conclusions:
Nearly 50 percent of subserous gallbladder carcinomas show an abnormal CD44 expression
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Adenocarcinoma
/
Neoplasias da Vesícula Biliar
Limite:
Adulto
/
Feminino
/
Humanos
/
Masculino
Idioma:
Espanhol
Revista:
Rev. méd. Chile
Assunto da revista:
Medicina
Ano de publicação:
2001
Tipo de documento:
Artigo
/
Documento de projeto
País de afiliação:
Chile
Similares
MEDLINE
...
LILACS
LIS